Genedx Holdings Corp Stock Market Value
| WGS Stock | 94.78 3.54 3.88% |
| Symbol | GeneDx |
Is there potential for Health Care Equipment & Supplies market expansion? Will GeneDx introduce new products? Factors like these will boost the valuation of GeneDx Holdings. Anticipated expansion of GeneDx directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about GeneDx Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.11 | Revenue Per Share | Quarterly Revenue Growth 0.519 | Return On Assets | Return On Equity |
Investors evaluate GeneDx Holdings Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating GeneDx Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause GeneDx Holdings' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between GeneDx Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if GeneDx Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, GeneDx Holdings' market price signifies the transaction level at which participants voluntarily complete trades.
GeneDx Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GeneDx Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GeneDx Holdings.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in GeneDx Holdings on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding GeneDx Holdings Corp or generate 0.0% return on investment in GeneDx Holdings over 90 days. GeneDx Holdings is related to or competes with Hinge Health, Kymera Therapeutics, TransMedics, Viking Therapeutics, Oscar Health, Immunovant, and Privia Health. GeneDx Holdings is entity of United States More
GeneDx Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GeneDx Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GeneDx Holdings Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 21.84 | |||
| Value At Risk | (7.88) | |||
| Potential Upside | 5.29 |
GeneDx Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneDx Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GeneDx Holdings' standard deviation. In reality, there are many statistical measures that can use GeneDx Holdings historical prices to predict the future GeneDx Holdings' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (0.28) |
GeneDx Holdings February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 2.81 | |||
| Coefficient Of Variation | (829.94) | |||
| Standard Deviation | 3.96 | |||
| Variance | 15.68 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (0.28) | |||
| Maximum Drawdown | 21.84 | |||
| Value At Risk | (7.88) | |||
| Potential Upside | 5.29 | |||
| Skewness | (0.19) | |||
| Kurtosis | 1.57 |
GeneDx Holdings Corp Backtested Returns
GeneDx Holdings Corp holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11 % return per unit of risk over the last 3 months. GeneDx Holdings Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GeneDx Holdings' Market Risk Adjusted Performance of (0.27), risk adjusted performance of (0.09), and Standard Deviation of 3.96 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.72, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GeneDx Holdings will likely underperform. At this point, GeneDx Holdings Corp has a negative expected return of -0.45%. Please make sure to check out GeneDx Holdings' total risk alpha, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if GeneDx Holdings Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.07 |
Very weak reverse predictability
GeneDx Holdings Corp has very weak reverse predictability. Overlapping area represents the amount of predictability between GeneDx Holdings time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GeneDx Holdings Corp price movement. The serial correlation of -0.07 indicates that barely 7.0% of current GeneDx Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 296.81 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.